An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLLAdam S. Kittai, Matthew S. Davids, Miguel Miranda et al.|Blood Advances|2024Cited by 18
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trialNadia Harbeck, Marion van Mackelenbergh, Eva Ciruelos et al.|Nature Medicine|2024Cited by 8